BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10387771)

  • 1. Tailored, not benchmarked. A fresh look at corporate planning.
    Campbell A
    Harv Bus Rev; 1999; 77(2):41-8, 50, 189. PubMed ID: 10387771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What's wrong with strategy?
    Campbell A; Alexander M
    Harv Bus Rev; 1997; 75(6):42-51. PubMed ID: 10174797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Managers' everyday decisions create or destroy your company's strategy.
    Bower JL; Gilbert CG
    Harv Bus Rev; 2007 Feb; 85(2):72-9, 154. PubMed ID: 17345681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating corporate advantage.
    Collis DJ; Montgomery CA
    Harv Bus Rev; 1998; 76(3):70-83. PubMed ID: 10179655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why business models matter.
    Magretta J
    Harv Bus Rev; 2002 May; 80(5):86-92, 133. PubMed ID: 12024761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing on capabilities: the new rules of corporate strategy.
    Stalk G; Evans P; Shulman LE
    Harv Bus Rev; 1992; 70(2):57-69. PubMed ID: 10117369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growing talent as if your business depended on it.
    Cohn JM; Khurana R; Reeves L
    Harv Bus Rev; 2005 Oct; 83(10):62-70, 155. PubMed ID: 16250625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fruitful flaws of strategy metaphors.
    von Ghyczy T
    Harv Bus Rev; 2003 Sep; 81(9):86-94, 133. PubMed ID: 12964396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming corner-office strategy into frontline action.
    Gadiesh O; Gilbert JL
    Harv Bus Rev; 2001 May; 79(5):72-9, 164. PubMed ID: 11345913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CEO as organizational architect: an interview with Xerox's Paul Allaire. Interview by Robert Howard.
    Allaire P
    Harv Bus Rev; 1992; 70(5):106-21. PubMed ID: 10121313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How risky is your company?
    Simons R
    Harv Bus Rev; 1999; 77(3):85-94, 209. PubMed ID: 10387580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why good companies go bad.
    Sull DN
    Harv Bus Rev; 1999; 77(4):42-8, 50-2, 183. PubMed ID: 10539208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stop making plans; start making decisions.
    Mankins MC; Steele R
    Harv Bus Rev; 2006 Jan; 84(1):76-84, 133. PubMed ID: 16447371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patching. Restitching business portfolios in dynamic markets.
    Eisenhardt KM; Brown SL
    Harv Bus Rev; 1999; 77(3):72-82, 208. PubMed ID: 10387579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxiety of learning. Interview by Diane L. Coutu.
    Schein EH
    Harv Bus Rev; 2002 Mar; 80(3):100-6, 134. PubMed ID: 11894378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's your strategy for managing knowledge?
    Hansen MT; Nohria N; Tierney T
    Harv Bus Rev; 1999; 77(2):106-16, 187. PubMed ID: 10387767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. We don't need another hero.
    Badaracco JL
    Harv Bus Rev; 2001 Sep; 79(8):120-6, 162. PubMed ID: 11550628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lure of global branding.
    Aaker DA; Joachimsthaler E
    Harv Bus Rev; 1999; 77(6):137-44, 217. PubMed ID: 10662002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic renewal for business units.
    Whitney JO
    Harv Bus Rev; 1996; 74(4):84-98. PubMed ID: 10158476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Level 5 leadership. The triumph of humility and fierce resolve.
    Collins J
    Harv Bus Rev; 2001 Jan; 79(1):66-76, 175. PubMed ID: 11189464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.